Molecular basis of fosmidomycin's action on the human malaria parasite Plasmodium falciparum.

Abstract

The human malaria parasite Plasmodium falciparum is responsible for the deaths of more than a million people each year. Fosmidomycin has been proven to be efficient in the treatment of P. falciparum malaria by inhibiting 1-deoxy-D-xylulose 5-phosphate reductoisomerase (DXR), an enzyme of the non-mevalonate pathway, which is absent in humans. However, the structural details of DXR inhibition by fosmidomycin in P. falciparum are unknown. Here, we report the crystal structures of fosmidomycin-bound complete quaternary complexes of PfDXR. Our study revealed that (i) an intrinsic flexibility of the PfDXR molecule accounts for an induced-fit movement to accommodate the bound inhibitor in the active site and (ii) a cis arrangement of the oxygen atoms of the hydroxamate group of the bound inhibitor is essential for tight binding of the inhibitor to the active site metal. We expect the present structures to be useful guides for the design of more effective antimalarial compounds.

• Authors: Tomonobu Umeda, Nobutada Tanaka, Yoshio Kusakabe, Masayuki Nakanishi, Yukio Kitade, Kazuo T Nakamura
• Journal: Scientific reports (Sci Rep) Vol. 1 Pg. 9 ( 2011) ISSN: 2045-2322 [Electronic] England
• PMID: 22355528 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Enzyme Inhibitors
• 1-deoxy-D-xylulose 5-phosphate reductoisomerase
• Aldose-Ketose Isomerases

Topics

• Aldose-Ketose Isomerases (chemistry)
• Binding Sites
• Computer Simulation
• Enzyme Inhibitors (chemistry)
• Humans
• Models, Chemical
• Models, Molecular
• Plasmodium falciparum (chemistry, enzymology)
• Protein Binding
• Protein Conformation